Trial intelligence / Profile preview

Quetiapine versus trazodone for sleep improvement in methadone maintenance patients

IRCT20180527039860N1Phase 3Completed

Sponsor
Babol University of Medical Sciences
Start
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of quetiapine and trazodone in sleep disorder (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: Sleep quality. Started Aug 2018; status: completed.

02

Drugs

quetiapinetrazodone
03

Conditions

sleep disorder

Beyond the preview

Go deeper on IRCT20180527039860N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180527039860N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call